Oppenheimer raises SiriusPoint stock price target on earnings beat
Oppenheimer raised its price target on SiriusPoint Ltd (NYSE: SPNT) to $31 from $27, citing strong Q3 2026 earnings. The company reported adjusted earnings of $0.74 per share, beating estimates, with revenue of $867.6 million. Oppenheimer updated its 2026 EPS estimate to $2.83 and introduced a 2028 estimate of $2.90, excluding one-time costs. SiriusPoint's core combined ratio remained steady at 90.1%.
How this was made
The 30-second read
Why it matters
The earnings beat and higher target suggest the stock may rally, but investors should monitor core loss ratios and upcoming portfolio transfers.
Market read
Earnings beat and analyst target raise provide fresh bullish catalyst for SPNT.
What to watch
Potential exposure to future catastrophe losses not reflected in the current guidance.
Background
SiriusPoint reported Q3 2026 adjusted EPS of $0.74 versus $0.64 consensus and revenue of $867.6 million, prompting Oppenheimer to lift its price target.
Ticker impact
Oppenheimer raised its price target on SiriusPoint to $31 after the company reported a Q3 earnings beat.
upward pressure as investors price in stronger earnings and higher guidance.
The price target increase from $27 to $31 reflects Oppenheimer's view that the stock is undervalued and earnings beat supports upside.
Market effects
Positive earnings and target raise may lift other specialty insurers.
Limited to U.S. insurance sector.
Minimal global impact.
Counterpoint
The target raise could be premature if underlying loss ratios deteriorate.
Key entities
- companySiriusPoint Ltd
Specialty insurer listed on NYSE.
- analystOppenheimer
Equity research firm that raised the price target.


